A detailed history of Wealth Alliance Advisory Group, LLC transactions in Incyte Corp stock. As of the latest transaction made, Wealth Alliance Advisory Group, LLC holds 4,420 shares of INCY stock, worth $320,405. This represents 0.07% of its overall portfolio holdings.

Number of Shares
4,420
Previous 4,420 -0.0%
Holding current value
$320,405
Previous $267,000 9.36%
% of portfolio
0.07%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 10, 2024

BUY
$52.16 - $64.19 $5,216 - $6,419
100 Added 2.31%
4,420 $277,000
Q4 2021

Jan 13, 2022

BUY
$63.34 - $74.11 $1,266 - $1,482
20 Added 0.47%
4,320 $317,000
Q4 2018

Jan 28, 2019

BUY
$58.5 - $69.94 $58,500 - $69,940
1,000 Added 30.3%
4,300 $273,000
Q2 2018

Jul 20, 2018

SELL
$60.85 - $83.98 $82,025 - $113,205
-1,348 Reduced 29.0%
3,300 $221,000
Q1 2018

Jun 01, 2018

BUY
$83.06 - $100.98 $386,062 - $469,355
4,648 New
4,648 $387,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Wealth Alliance Advisory Group, LLC Portfolio

Follow Wealth Alliance Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Alliance Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Alliance Advisory Group, LLC with notifications on news.